Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate | Pfizer

https://www.pfizer.com/news/press-release/press-release-detail/valneva-and-pfizer-announce-initiation-phase-2-study-lyme